ATRI
Atrion Corporation
Set alert
52-week range unavailable
- Open
- 459.75
- Prev close
- 459.92
- Mkt cap
- 809.44M
- Vol
- 29.52K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 1.91%
More statistics
- Low
- 459.75
- High
- 460.26
- Forward P/E
- 0.00
- Beta
- 0.69
- Short ratio
- 2.04
- Inst. own
- 71.86%
- Dividend
- 8.80
- Ex-div date
- Jun 13, 2024
- Earnings
- Aug 8, 2024
- 50-d avg
- 457.07
- 200-d avg
- 410.03
- 1y target
- 0.00
Key statistics
- Market cap
- 809.44M
- Enterprise value
- 791.85M
- Trailing P/E
- 64.50
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 4.46
- Price / book
- 3.39
- EPS (TTM)
- 7.13
- Beta
- 0.69
- Dividend yield
- 1.91%
- Payout ratio
- 123.60%
- Profit margin
- 6.92%
- Revenue (TTM)
- 181.60M
- Revenue growth
- 11.30%
- Free cash flow
- 26.30M
- Total cash
- 17.59M
- Total debt
- 0
- Return on equity
- 5.23%
- Shares outstanding
- 1.76M
- Short % of float
- 3.79%
- 50-day average
- 457.07
- 200-day average
- 410.03
Analyst view
Consensus: none
- Strong buy0
- Buy0
- Hold0
- Sell1
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 10, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Feb 29, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 8, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 24, 2016 | BWS Financial | init | — | Sell |
About Atrion Corporation
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- atrioncorp.com
News
- Is Ares Management (ARES) a Value Opportunity After Q1 2026? GAAP EPS $0.46 (miss vs $1.39 est), Revenue not disclosed; GF Score 83/100, GF Value: 32.5% undervalued
- ATRI WELCOMES TWO INDUSTRY LEADERS TO ITS BOARD OF DIRECTORS
- Smaller But Mighty: 3 Small-Cap Stocks for Long-Term Dividend Growth
- Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs
- Atrion Reports Second Quarter 2024 Results
- ATRI ALERT: The M&A Class Action Firm Investigates the Merger and August 19, 2024 Shareholder Vote of Atrion Corporation
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, CALT on Behalf of Shareholders
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, HTLF on Behalf of Shareholders
- URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation – ATRI
- URGENT UPDATE: The M&A Class Action Firm Investigates Merger and Imminent Vote on August 19, 2024, of Atrion Corporation - ATRI
Your note
Sign in to keep a note on ATRI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ATHEY PRESTON G. | Director | Purchase | Nov 30, 2023 | 1,368 |
| BANKES JEANNETTE | Director | Stock Award(Grant) | Sep 19, 2023 | 186 |
| BATTAT DAVID A | Chief Executive Officer | Stock Award(Grant) | Aug 20, 2024 | 0 |
| BATTAT EMILE A | Director | Conversion of Exercise of derivative security | Jun 30, 2024 | 150,616 |
| FERGUSON CINDY | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 7, 2024 | 118 |
| MORGAN HUGH JACKSON JR | Director | Stock Award(Grant) | May 22, 2023 | 10,348 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 11.60% | 204,079 | 115.45M | Jun 29, 2023 |
| Neuberger Berman Group, LLC | 10.56% | 185,786 | 105.10M | Jun 29, 2023 |
| T. Rowe Price Investment Management, Inc. | 6.30% | 110,803 | 62.68M | Jun 29, 2023 |
| Blackrock Inc. | 6.22% | 109,494 | 61.94M | Jun 29, 2023 |
| Vanguard Group Inc | 4.71% | 82,827 | 46.86M | Jun 29, 2023 |
| Dimensional Fund Advisors LP | 2.95% | 51,992 | 29.41M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Neuberger & Berman Genesis Fund | 7.02% | 123,510 | 69.87M | Jun 29, 2023 |
| Price (T.Rowe) Small-Cap Value Fund | 3.89% | 68,517 | 38.76M | Jun 29, 2023 |
| Virtus Equity Tr-Virtus KAR Small Cap Core Fd | 2.78% | 48,880 | 27.65M | Jun 29, 2023 |
| Vanguard Total Stock Market Index Fund | 2.26% | 39,845 | 22.54M | Jun 29, 2023 |
| iShares Russell 2000 ETF | 1.72% | 30,257 | 14.07M | Aug 30, 2023 |
| Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 1.68% | 29,601 | 16.75M | Jun 29, 2023 |